Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Goodwill (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Goodwill over the past 15 years, most recently at $13.9 million for Q2 2025.

  • For Q2 2025, Goodwill changed 0.0% year-over-year to $13.9 million; the TTM value through May 2025 reached $13.9 million, changed 0.0%, while the annual FY2025 figure was $13.9 million, 0.0% changed from the prior year.
  • Goodwill for Q2 2025 was $13.9 million at Lifecore Biomedical, Inc. \De\, roughly flat from $13.9 million in the prior quarter.
  • Over five years, Goodwill peaked at $13.9 million in Q2 2022 and troughed at $13.9 million in Q1 2021.
  • A 5-year average of $13.9 million and a median of $13.9 million in 2021 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: tumbled 82.03% in 2021 and later rose 0.14% in 2022.
  • Year by year, Goodwill stood at $13.9 million in 2021, then changed by 0.0% to $13.9 million in 2022, then changed by 0.0% to $13.9 million in 2023, then changed by 0.0% to $13.9 million in 2024, then changed by 0.0% to $13.9 million in 2025.
  • Business Quant data shows Goodwill for LFCR at $13.9 million in Q2 2025, $13.9 million in Q1 2025, and $13.9 million in Q4 2024.